Revolution Medicines Highlights Slate of Diverse Board of Directors Nominees for Upcoming 2021 Annual Shareholder Meeting

NEXT STORY
Respiratory Devices And Equipment (Therapeutic And Diagnostic) Global Market Report 2021: COVID 19 Implications And Growth to 2030
PREV STORY
Myriad Genetics to Update Progress on Transformation Plan and Growth Initiatives, Share Long-Term Financial Outlook at 2021 Investor Day
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Pieris Pharmaceuticals to Present at Investor Conferences in November

BOSTON, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage ...

author_avatar
NASDAQ Market News

CytomX Therapeutics Announces Presentations at 2018 ASCO Annual Meeting

- Preliminary first-in-human data to be presented from PROCLAIM-CX-072 trial of a PD-L1 Probody ...

author_avatar
NASDAQ Market News

Claus Frisenberg Pedersen, CCO i Oncology Venture köper aktier i bolaget

Pressmeddelande Claus Frisenberg Pedersen, CCO i Oncology Venture köper aktier i bolaget Hørsholm, Denmark ...

author_avatar
NASDAQ Market News